Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05VWZ
|
|||
Former ID |
DNC006518
|
|||
Drug Name |
2-(3-carboxybenzyl)succinic acid
|
|||
Synonyms |
2-(3-carboxybenzyl)succinic acid; carboxylate, 39; 2-[(3-carboxyphenyl)methyl]butanedioic Acid; Butanedioic acid, 2-[(3-carboxyphenyl)methyl]-; CHEMBL209190; BDBM17782
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H12O6
|
|||
Canonical SMILES |
C1=CC(=CC(=C1)C(=O)O)CC(CC(=O)O)C(=O)O
|
|||
InChI |
1S/C12H12O6/c13-10(14)6-9(12(17)18)5-7-2-1-3-8(4-7)11(15)16/h1-4,9H,5-6H2,(H,13,14)(H,15,16)(H,17,18)
|
|||
InChIKey |
WCLWDNBZTFVGIR-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glutamate carboxypeptidase II (GCPII) | Target Info | Inhibitor | [1] |
KEGG Pathway | Alanine, aspartate and glutamate metabolism | |||
Metabolic pathways | ||||
Vitamin digestion and absorption | ||||
NetPath Pathway | TCR Signaling Pathway | |||
TNFalpha Signaling Pathway | ||||
Reactome | Amino acid synthesis and interconversion (transamination) | |||
WikiPathways | One Carbon Metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain. J Med Chem. 2006 May 18;49(10):2876-85. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.